Connection

Marc Chimowitz to Aspirin

Back to Details
This is a "connection" page, showing publications Marc Chimowitz has written about Aspirin.
Marc Chimowitz
Connection Strength
2.409
Aspirin
  1. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.619
  2. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005 Mar 31; 352(13):1305-16.
    View in: PubMed
    Score: 0.212
  3. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022 04; 21(4):355-368.
    View in: PubMed
    Score: 0.171
  4. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. J Neurosurg. 2018 09; 129(3):702-710.
    View in: PubMed
    Score: 0.127
  5. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995 Aug; 45(8):1488-93.
    View in: PubMed
    Score: 0.109
  6. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
    View in: PubMed
    Score: 0.098
  7. Death associated with asymptomatic carotid artery stenosis: long-term clinical evaluation. VA Cooperative Study 167 Group. J Vasc Surg. 1993 Dec; 18(6):1002-9; discussion 1009-11.
    View in: PubMed
    Score: 0.097
  8. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.097
  9. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
    View in: PubMed
    Score: 0.083
  10. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
    View in: PubMed
    Score: 0.082
  11. Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis. 2011; 31(6):588-91.
    View in: PubMed
    Score: 0.081
  12. Mechanism of stroke in patients taking aspirin. Neurology. 1990 Nov; 40(11):1682-5.
    View in: PubMed
    Score: 0.078
  13. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009 Mar; 40(3):719-25.
    View in: PubMed
    Score: 0.068
  14. Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study. Clin Trials. 2008; 5(1):23-30.
    View in: PubMed
    Score: 0.064
  15. Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2007 Sep-Oct; 16(5):216-9.
    View in: PubMed
    Score: 0.063
  16. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke. 2007 Jul; 38(7):2055-62.
    View in: PubMed
    Score: 0.062
  17. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006 Oct 10; 67(7):1275-8.
    View in: PubMed
    Score: 0.059
  18. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006 Jan 31; 113(4):555-63.
    View in: PubMed
    Score: 0.056
  19. Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee. Neurology. 2022 03 22; 98(12):486-498.
    View in: PubMed
    Score: 0.043
  20. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.027
  21. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Veterans Affairs Cooperative Study Group 167. Stroke. 1994 Apr; 25(4):759-65.
    View in: PubMed
    Score: 0.025
  22. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.024
  23. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):1999-2003.
    View in: PubMed
    Score: 0.018
  24. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
    View in: PubMed
    Score: 0.017
  25. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007; 24(2-3):283-8.
    View in: PubMed
    Score: 0.016
  26. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology. 2006 May 09; 66(9):1344-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.